MRFAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.663800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.701200E-01
Normal-vs-Stage2
7.183800E-01
Normal-vs-Stage3
4.598800E-01
Normal-vs-Stage4
9.984400E-01
Stage1-vs-Stage2
6.430000E-01
Stage1-vs-Stage3
3.099600E-01
Stage1-vs-Stage4
9.656400E-01
Stage2-vs-Stage3
3.883000E-01
Stage2-vs-Stage4
6.759800E-01
Stage3-vs-Stage4
4.017800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.509000E-01
Normal-vs-AfricanAmerican
8.943800E-01
Normal-vs-Asian
9.851600E-01
Caucasian-vs-AfricanAmerican
6.671400E-01
Caucasian-vs-Asian
7.669800E-01
AfricanAmerican-vs-Asian
8.860400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.319800E-01
Normal-vs-Female
9.589800E-01
Male-vs-Female
1.277240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.689800E-01
Normal-vs-Age(41-60Yrs)
7.062400E-01
Normal-vs-Age(61-80Yrs)
7.154400E-01
Normal-vs-Age(81-100Yrs)
5.642600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.899200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.889600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.132400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.138600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.093370E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.293200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.395000E-01
Normal-vs-Daily Drinker
9.922800E-01
Normal-vs-Weekly Drinker
7.878800E-01
Normal-vs-Occasional Drinker
6.539400E-01
Normal-vs-Social Drinker
8.524400E-01
Non Drinker-vs-Daily Drinker
1.046040E-01
Non Drinker-vs-Weekly Drinker
5.198000E-01
Non Drinker-vs-Occasional Drinker
1.728180E-02
Non Drinker-vs-Social Drinker
2.737000E-01
Daily Drinker-vs-Weekly Drinker
5.635000E-01
Daily Drinker-vs-Occasional Drinker
3.763400E-01
Daily Drinker-vs-Social Drinker
7.227000E-01
Weekly Drinker-vs-Occasional Drinker
2.319400E-01
Weekly Drinker-vs-Social Drinker
8.015600E-01
Occasional Drinker-vs-Social Drinker
2.622600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.858200E-01
Normal-vs-Grade 2
9.958600E-01
Normal-vs-Grade 3
9.897000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.768200E-01
Grade 1-vs-Grade 3
9.546200E-01
Grade 1-vs-Grade 4
9.858200E-01
Grade 2-vs-Grade 3
6.681600E-01
Grade 2-vs-Grade 4
9.958600E-01
Grade 3-vs-Grade 4
9.897000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.925400E-01
Normal-vs-NonDiabetic
9.351000E-01
Diabetic-vs-NonDiabetic
5.188400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.541800E-01
Normal-vs-NoPancreatitis
8.876200E-01
Pancreatitis-vs-NoPancreatitis
5.625800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.276800E-01
Normal-vs-N1
7.533400E-01
N0-vs-N1
2.324400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.786400E-01
Normal-vs-TP53-NonMutant
7.112800E-01
TP53-Mutant-vs-TP53-NonMutant
3.513200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
